Auxly Cannabis Eyes Global Growth As Q3 Revenue Hits CA$39.9M

Auxly Cannabis Group Inc. (TSX: XLY) (OTCQB: CBWTF) reported on Thursday a 20% year-over-year increase in revenue, reaching CA$39.9 million ($28.5 million) in the third quarter of fiscal 2025.

“Through product innovation, increased capacity utilization, favourable pricing and product mix, the Auxly team delivered another strong quarter of revenue and earnings growth,” Hugo Alves, the company’s CEO, said.

Q3 2025 Financial Highlights

• Gross profit totaled CA$28.2 million, resulting in a 71% gross profit margin as compared to CA$17.1 million (52%) during the same period in 2024.
• Selling, general and administrative expenses were CA$11.6 million, CA$3.2 million or 38% higher than the same period in 2024.
• Net income was CA$20.5 million, which included an after-tax gain of CA$8.1 million on the Imperial Debenture Settlement, representing a basic net income of CA$0.02 per share and CA$0.01 per share on a diluted basis as compared to a net income of CA$3.2 million in the same period in 2024.
• Adjusted EBITDA came in positive at CA$12.3 million, representing an improvement of CA$4 million over the same period in 2024, primarily as a result of improved gross profits, partially offset by higher selling expenses and wages and benefits to support higher sales.
• Cash flow from operations, before working capital changes, was CA$11 million, representing an increase of 82% year-over-year.
• Cash at quarter end totaled CA$30.5 million.

Outlook

Auxly plans on driving sustainable, profitable growth while focusing on innovation, efficiency and strong financial management.

In addition to continued expansion in the Canadian cannabis market, the company also sees long-term potential in global markets. It remains focused on strengthening its leadership in cannabis categories such as dried flower, vapes and pre-rolls.